✦ LIBER ✦

Cancer immunotherapy using local interleukin 2 administration

✍ Scribed by J. Bubeník; M. Indrová

Book ID: 104176981
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 330 KB
Volume: 16
Category: Article
ISSN: 0165-2478
DOI: 10.1016/0165-2478(87)90162-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Local immunotherapy of cancer with inter

Local immunotherapy of cancer with interleukin 2

✍ Jan Bubeník 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 575 KB

Immunotherapy of cancer using interleuki

Immunotherapy of cancer using interleukin 2: current status and future prospects

✍ Steven A. Rosenberg 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 681 KB

Local immunotherapy of spontaneous felin

Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)

✍ Jourdier, T-M; Moste, C; Bonnet, M-C; Delisle, F; Tafani, J-P; Devauchelle, P; T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Immunotherapy of cancer using IL-2

✍ David Berd 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Immunotherapy of advanced renal cell can

Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α

✍ H. Kirchner; W. Riese; E. Allhoff; H. Poliwoda; J. Atzpodien 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

The combined administration of subcutaneous recombinant human interleukin-2 (rIL-2) and interferon-a (rIFN-~) was studied in a phase II trial on patients with advanced progressive renal cell cancer. Safety, tolerance and clinical response rate of this outpatient treatment protocol were assessed in 2

Sequential immunotherapy using interleuk

Sequential immunotherapy using interleukin-1 followed by interleukin-2 of ascitic MOPC104E-bearing mice

✍ Takehisa Harada; Norimichi Kan; Takashi Okino; You Ichinose; Yoshio Moriguchi; L 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 688 KB